Migraine is one of the most prevalent neurological disorders in the United States, affecting approximately 39 million people according to the American Migraine Foundation (AMF). Despite this prevalence, headache clinics remain among the most administratively burdened practices in neurology — largely because the treatments that have transformed migraine management over the past decade, including CGRP monoclonal antibodies and onabotulinumtoxinA (Botox), carry payer requirements that generate enormous documentation and prior authorization workload.
The CGRP Authorization Gauntlet
Calcitonin gene-related peptide (CGRP) inhibitors — erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality), and eptinezumab (Vyepti) — have become first-line preventive therapies for episodic and chronic migraine. However, virtually every commercial payer and most Medicaid plans impose step therapy requirements before approving these agents. Patients must typically demonstrate failure of two or more oral preventive medications from specified drug classes — tricyclics, beta-blockers, anticonvulsants, or calcium channel blockers — before a CGRP inhibitor will be authorized.
The American Academy of Neurology (AAN) has published guidance highlighting that step therapy delays for CGRP inhibitors frequently extend patient suffering by three to six months while required trials are documented. A virtual assistant trained in neurology headache workflows manages the step therapy documentation process systematically: pulling prior medication trial records from the EHR, formatting the clinical history narrative per payer requirements, and tracking appeal timelines when first-pass denials are issued.
Botox Program Administration
OnabotulinumtoxinA is FDA-approved for chronic migraine — defined as 15 or more headache days per month — and must be administered every 12 weeks to maintain payer authorization. The PREEMPT injection protocol requires precise documentation of the 31-injection-site pattern, headache day frequency data from patient diaries, and functional impairment measures. Every authorization cycle, the practice must resubmit clinical documentation demonstrating ongoing medical necessity.
Managing the Botox program for a headache clinic involves scheduling injection appointments at 12-week intervals for a cohort of chronic migraine patients, tracking headache diary compliance so data is available at authorization renewal, and submitting reauthorization packets before the current authorization expires. When authorizations lapse, patients miss injection cycles — which both undermines therapeutic outcomes and exposes the practice to lost procedure revenue.
A virtual assistant handles all of this: sending appointment reminders at appropriate intervals, contacting patients who have not submitted headache diaries, assembling reauthorization packets from EHR data, and monitoring payer portal status. This keeps the Botox program running without requiring a dedicated clinical coordinator.
Headache Diary and Patient Follow-Up
Payer criteria for both CGRP inhibitors and Botox frequently require headache diary data as proof of treatment response and ongoing medical necessity. Patients completing 90-day headache diaries — recording frequency, severity, duration, and medication use — often need reminders and support to maintain compliance. A virtual assistant manages this outreach proactively, contacting patients between appointments to reinforce diary completion and flagging patients who have gone silent to the care team.
The VA also manages new patient intake for the headache clinic, gathering referring provider records, prior treatment histories, and current medication lists before the first appointment — ensuring the physician has a complete clinical picture without front-desk staff spending time on pre-visit chart preparation.
Staffing Headache Clinics for Prior Auth Volume
Headache clinics with a high proportion of CGRP and Botox patients can generate more than 50 prior authorization submissions per month — a volume that rapidly overwhelms a general front-desk team. A virtual assistant dedicated to the headache practice manages this volume consistently, maintaining a tracking log of all active authorizations, their expiration dates, and next resubmission windows.
According to AAN workforce data, administrative burden is among the top three drivers of neurologist burnout, with prior authorization cited as the single most time-consuming non-clinical task. Offloading this work to a trained VA directly addresses that pressure point. For neurology headache clinics ready to stabilize their CGRP and Botox program administration, Stealth Agents provides virtual assistants with headache clinic-specific training.
Sources
- American Migraine Foundation (AMF). "Migraine Facts." americanmigrainefoundation.org
- American Academy of Neurology (AAN). "Prior Authorization and Administrative Burden in Neurology." aan.com
- Allergan/AbbVie. "PREEMPT Clinical Protocol for OnabotulinumtoxinA." botoxmedical.com